Article Details

Ionis Pharmaceutical Inc.'s (NASDAQ: IONS) Partner, Roche Designs New Phase II ...

Retrieved on: 2022-01-27 05:34:13

Tags for this article:

Click the tags to see associated articles and topics

Ionis Pharmaceutical Inc.'s (NASDAQ: IONS) Partner, Roche Designs New Phase II .... View article details on hiswai:

Excerpt

Roche is currently planning a Phase II clinical study to evaluate multiple tominersen doses in a teen patient population with a reduced disease load.

Article found on: biopharmajournal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up